Color Blind Test - Ishihara is a health screening app for iOS and Android that provides Ishihara-style color vision testing and accessibility simulation.
Product velocity
Maintenance
Daily rank 🇺🇸
—
Health & Fitness
Sentiment
—
—
Nemesis
EyeQue Insight
The App DNA
What makes this app unique?
Users hire this app for immediate, private confirmation of color vision deficiency without the cost or time of a clinical appointment.
For Individuals concerned about color vision, parents screening children, and designers needing accessibility verification tools.
Key features
Standardized visual plates for screening common color vision deficiencies.
Visual filter tool that mimics vision differences for design accessibility.
Generates summary reports for sharing with eye care professionals.
How much does it cost?
The app operates on a fully free, ad-supported model with no current IAP or subscription gates.
Velocity
Maintenance developmentperformanceUX improvementsShow more...
The app maintains a low-frequency release cadence, averaging approximately 0.2 releases per week over the observed period. Development is currently focused on stability and performance, with no new features or live-ops events identified in recent updates. The publisher utilizes generic release notes, providing limited transparency into the specific technical changes being deployed. The development trend is stable but strictly limited to maintenance-level updates.
Who built it?
Suman Sharma
6 apps tracked · Health & Fitness
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Color Blind Test - Ishihara
How's the Health & Fitness market?
The app occupies the casual, single-purpose screening niche, competing against established vision-health brands that offer broader tracking. Its lack of monetization gates creates a low-barrier entry but limits the revenue needed to compete with professional-grade clinical tools.
Read the market outlookThe rivals identified
By EyeQue Corporation
EyeQue competes directly by offering vision screening and tracking tools that target the same health-conscious demographic seeking at-home eye diagnostics.
- Offers comprehensive optical vision screening beyond simple color blindness testing for broader utility
- Includes multi-user sharing capabilities that allow families to track vision health on one device
- Provides long-term vision tracking data which encourages higher user retention than a static test
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Color Blind Test - Ishihara
Where is it heading?
The vision-screening market is consolidating around apps that offer long-term health tracking rather than static tests. Without a transition to a premium model or clinical-grade features, this app will likely remain a low-utility tool for casual users while losing ground to rivals with higher retention loops.
- Recent updates focused on minor performance improvements, indicating the app remains in a maintenance-mode development cycle.
- The absence of monetization gates limits the capital available to defend against better-funded competitors entering the vision-screening space.
The SWOT
- Simplified Ishihara interface reduces screening friction
- Simulator tool provides unique design-accessibility utility
- B2B partnerships with design schools for accessibility tools
- Premium reporting tiers would unlock revenue streams
Next best moves
Introduce premium PDF reporting tier because current free model lacks revenue levers → increase average revenue per user
+ 1 more prioritized moveThe counter-intuitive read
The app's lack of monetization is a strategic vulnerability, not a growth lever…
Read the full takeFeature gaps
Multi-user tracking (available in EyeQue Insight but missing here) +1
Since the last report: The app has transitioned from a maintenance-only posture to a proactive development strategy focused on monetization and multi-user utility to counter clinical-grade competitors.
Bottom line
The app captures the casual screening market through simplicity, but its zero-monetization model prevents it from scaling against clinical-grade rivals, so the PM must prioritize a premium reporting tier to fund long-term development.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated